Honorary Professor

Rajiv Khanna

Email: 

Availability

Honorary Professor Rajiv Khanna is:
Available for supervision

Fields of research

Biological Sciences Immunology Medical microbiology

Qualifications

  • Bachelor of Science, Panjab University
  • Masters (Coursework) of Science, Panjab University
  • Doctor of Philosophy, Institution to be confirmed

Search Professor Rajiv Khanna’s works on UQ eSpace

84 works between 1998 and 2025
All (84) Journal Article (83) Conference Publication (1)

1 - 20 of 84 works

2025

Journal Article

Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease

Henden, Andrea S, Lineburg, Katie E, Panikkar, Archana, Mahajan, Arushi, Nelles, Ricky, Wright, Emma, Crooks, Pauline, Raju, Jyothy, Le Texier, Laetitia, Swaminathan, Srividhya, Beagley, Leone, Best, Shannon, Solomon, Matthew, Reddiex, Hilary, Kennedy, Glen, Tey, Siok‐Keen, Neller, Michelle A, Khanna, Rajiv and Smith, Corey (2025). Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease. Clinical & Translational Immunology, 14 (6) e70038, e70038. doi: 10.1002/cti2.70038

Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease

2024

Journal Article

Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis

Ranganathan, Dwarakanathan, Leibowitz, Saskia, John, George T., Neller, Michelle A., Ambalathingal, George R., Beagley, Leone, Panikkar, Archana, Best, Shannon, Raju, Jyothy, Reddiex, Hilary, Ratanjee, Sharad, Ng, Monica Suet Ying, Smith, Corey and Khanna, Rajiv (2024). Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis. Clinical & Translational Immunology, 13 (11) e70015, e70015. doi: 10.1002/cti2.70015

Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis

2024

Journal Article

EphA3 CAR T cells are effective against glioblastoma in preclinical models

Martins, Paulo, D'Souza, Rochelle C. J., Skarne, Niclas, Lekieffre, Lea, Horsefield, Shane, Ranjankumar, Madusha, Li, Xiang, Le, Thuy T., Smith, Fiona, Smith, Corey, Burrows, Jacqueline, Day, Bryan W. and Khanna, Rajiv (2024). EphA3 CAR T cells are effective against glioblastoma in preclinical models. Journal for ImmunoTherapy of Cancer, 12 (8) e009403, 1-13. doi: 10.1136/jitc-2024-009403

EphA3 CAR T cells are effective against glioblastoma in preclinical models

2023

Journal Article

Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity

Duette, Gabriel, Lee, Eunok, Martins Costa Gomes, Gabriela, Tungatt, Katie, Doyle, Chloe, Stylianou, Vicki V., Lee, Ashley, Maddocks, Susan, Taylor, Janette, Khanna, Rajiv, Bull, Rowena A., Martinello, Marianne, Sandgren, Kerrie J., Cunningham, Anthony L. and Palmer, Sarah (2023). Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity. ImmunoHorizons, 7 (6), 508-527. doi: 10.4049/immunohorizons.2300034

Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity

2022

Journal Article

Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3

Swaminathan, Srividhya, Lineburg, Katie E., Panikkar, Archana, Raju, Jyothy, Murdolo, Lawton D., Szeto, Christopher, Crooks, Pauline, Le Texier, Laetitia, Rehan, Sweera, Dewar-Oldis, Michael J., Barnard, Peter J., Ambalathingal, George R., Neller, Michelle A., Short, Kirsty R., Gras, Stephanie, Khanna, Rajiv and Smith, Corey (2022). Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3. Nature Communications, 13 (1) 6387, 1-6. doi: 10.1038/s41467-022-34180-1

Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3

2022

Journal Article

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants

Panikkar, Archana, Lineburg, Katie E., Raju, Jyothy, Chew, Keng Yih, Ambalathingal, George R., Rehan, Sweera, Swaminathan, Srividhya, Crooks, Pauline, Le Texier, Laetitia, Beagley, Leone, Best, Shannon, Solomon, Matthew, Matthews, Katherine K., Srihari, Sriganesh, Neller, Michelle A., Short, Kirsty R., Khanna, Rajiv and Smith, Corey (2022). SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants. PLoS Pathogens, 18 (2) e1010339, 1-18. doi: 10.1371/journal.ppat.1010339

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants

2021

Journal Article

Rapid whole‐blood assay to detect SARS‐CoV‐2‐specific memory T‐cell immunity following a single dose of AstraZeneca ChAdOx1‐S COVID‐19 vaccine

Lineburg, Katie E, Neller, Michelle A, Ambalathingal, George R, Le Texier, Laetitia, Raju, Jyothy, Swaminathan, Srividhya, Lekieffre, Lea, Smith, Caitlyn, Rehan, Sweera, Crooks, Pauline, Panikkar, Archana, Srihari, Sriganesh, Khanna, Rajiv and Smith, Corey (2021). Rapid whole‐blood assay to detect SARS‐CoV‐2‐specific memory T‐cell immunity following a single dose of AstraZeneca ChAdOx1‐S COVID‐19 vaccine. Clinical and Translational Immunology, 10 (8) e1326, 1-7. doi: 10.1002/cti2.1326

Rapid whole‐blood assay to detect SARS‐CoV‐2‐specific memory T‐cell immunity following a single dose of AstraZeneca ChAdOx1‐S COVID‐19 vaccine

2021

Journal Article

Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity

Lee, Eunok, Sandgren, Kerrie, Duette, Gabriel, Stylianou, Vicki V., Khanna, Rajiv, Eden, John-Sebastian, Blyth, Emily, Gottlieb, David, Cunningham, Anthony L. and Palmera, Sarah (2021). Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity. Journal of Virology, 95 (6) 02002. doi: 10.1128/JVI.02002-20

Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity

2021

Journal Article

EBV and myeloid-derived suppressor cells

Sinha, Debottam and Khanna, Rajiv (2021). EBV and myeloid-derived suppressor cells. Blood, 137 (2), 148-150. doi: 10.1182/blood.2020008640

EBV and myeloid-derived suppressor cells

2021

Journal Article

'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies

Sinha, Debottam, Srihari, Sriganesh, Beckett, Kirrliee, Le Texier, Laetitia, Solomon, Matthew, Panikkar, Archana, Ambalathingal, George R., Lekieffre, Lea, Crooks, Pauline, Rehan, Sweera, Neller, Michelle A., Smith, Corey and Khanna, Rajiv (2021). 'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies. Journal for Immunotherapy of Cancer, 9 (2) e001608, e001608. doi: 10.1136/jitc-2020-001608

'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies

2020

Journal Article

Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study

Altaf, Mohammed, Lineburg, Katie E., Crooks, Pauline, Rehan, Sweera, Matthews, Katherine K., Neller, Michelle A, Ambalathingal, George R., Sinha, Debottam, Grant, Michelle, Hopkins, Peter M. A., Chambers, Daniel, Khanna, Rajiv and Smith, Corey (2020). Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study. The Journal of infectious diseases, 224 (2), 312-317. doi: 10.1093/infdis/jiaa750

Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study

2020

Journal Article

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis

Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2020). Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI insight, 5 (20) e144624. doi: 10.1172/jci.insight.144624

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis

2020

Journal Article

Proteome-wide analysis of T-cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile

Ambalathingal, George R., Francis, Ross S., Corvino, Dillon, Srihari, Sriganesh, Aftab, Blake T., Smith, Corey and Khanna, Rajiv (2020). Proteome-wide analysis of T-cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile. Clinical and Translational Immunology, 9 (1) e01102. doi: 10.1002/cti2.1102

Proteome-wide analysis of T-cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile

2020

Journal Article

Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases

Lineburg, Katie E., Srihari, Sriganesh, Altaf, Mohammed, Swaminathan, Srividhya, Panikkar, Archana, Raju, Jyothy, Crooks, Pauline, Ambalathingal, George R., Martins, Jose Paulo, Matthews, Katherine K., Neller, Michelle A., Khanna, Rajiv and Smith, Corey (2020). Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases. Clinical and Translational Immunology, 9 (12) e1219, e1219. doi: 10.1002/cti2.1219

Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases

2020

Journal Article

Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors

Sinha, Debottam, Smith, Corey and Khanna, Rajiv (2020). Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors. Trends in Molecular Medicine, 27 (1), 75-90. doi: 10.1016/j.molmed.2020.09.005

Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors

2019

Journal Article

T cell repertoire remodelling following post-transplant T cell therapy coincides with clinical response

Smith, Corey, Corvino, Dillon, Beagley, Leone, Rehan, Sweera, Neller, Michelle A., Crooks, Pauline, Matthews, Katherine K., Solomon, Matthew, Le Texier, Laetitia, Campbell, Scott, Francis, Ross S., Chambers, Daniel and Khanna, Rajiv (2019). T cell repertoire remodelling following post-transplant T cell therapy coincides with clinical response. Journal of Clinical Investigation, 129 (11), 5020-5032. doi: 10.1172/jci128323

T cell repertoire remodelling following post-transplant T cell therapy coincides with clinical response

2019

Journal Article

Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy

Walker, David G., Shakya, Reshma, Morrison, Beth, Neller, Michelle A, Matthews, Katherine K, Nicholls, John, Smith, Corey and Khanna, Rajiv (2019). Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy. Clinical and Translational Immunology, 8 (11) e01088. doi: 10.1002/cti2.1088

Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy

2018

Journal Article

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight, 3 (22) e124714. doi: 10.1172/jci.insight.124714

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

2018

Journal Article

Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: a single-arm open-label phase I clinical trial

Smith, Corey, Beagley, Leone, Rehan, Sweera, Neller, Michelle A., Crooks, Pauline, Solomon, Matthew, Holmes-Liew, Chien-Li, Holmes, Mark, McKenzie, Scott, Hopkins, Peter, Campbell, Scott, Francis, Ross, Chambers, Daniel and Khanna, Rajiv (2018). Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: a single-arm open-label phase I clinical trial. Clinical Infectious Diseases, 68 (4), 632-640. doi: 10.1093/cid/ciy549

Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: a single-arm open-label phase I clinical trial

2018

Journal Article

Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients

Hardy, Kristine, Smith, Corey, Tu, Wen Juan, McCuaig, Robert, Panikkar, Archana, Dasari, Vijayendra, Wu, Fan, Tey, Siok-Keen, Hill, Geoffrey R., Khanna, Rajiv and Rao, Sudha (2018). Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients. Blood Advances, 2 (6), 656-668. doi: 10.1182/bloodadvances.2018015909

Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients

Past funding

  • 2002
    Development of vaccination strategies against EBV-associated nasopharyngeal carcinoma using latent membrane protein 1 (LMP1)
    University of Queensland Research Development Grants Scheme
    Open grant

Availability

Honorary Professor Rajiv Khanna is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Designing Therapeutic Strategies Targeting KRAS

    Principal Advisor

    Other advisors: Honorary Professor Kum Kum Khanna

  • Doctor Philosophy

    Adoptive T-cell therapy for HPV associated cancers

    Principal Advisor

  • Doctor Philosophy

    Breaking barriers: unlocking the potential of cytomegalovirus-specific T cells in allogeneic CAR T cell therapies

    Principal Advisor

    Other advisors: Honorary Professor Kum Kum Khanna

  • Doctor Philosophy

    Investigating the differences between vaccine and infection induced T cell immunity to SARS-CoV-2

    Associate Advisor

    Other advisors: Professor Kirsty Short

  • Doctor Philosophy

    Combining spatial technology and gene expression signatures to characterize potent adoptive T cell immunotherapies

    Associate Advisor

Completed supervision

Enquiries

For media enquiries about Honorary Professor Rajiv Khanna's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au